Cargando…
Persistent Molecular Disease in Adult Patients With AML Evaluated With Whole-Exome and Targeted Error-Corrected DNA Sequencing
PURPOSE: Persistent molecular disease (PMD) after induction chemotherapy predicts relapse in AML. In this study, we used whole-exome sequencing (WES) and targeted error-corrected sequencing to assess the frequency and mutational patterns of PMD in 30 patients with AML. MATERIALS AND METHODS: The stu...
Autores principales: | Slade, Michael J., Ghasemi, Reza, O'Laughlin, Michelle, Burton, Tasha, Fulton, Robert S., Abel, Haley J., Duncavage, Eric J., Ley, Timothy J., Jacoby, Meagan A., Spencer, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530963/ https://www.ncbi.nlm.nih.gov/pubmed/37079859 http://dx.doi.org/10.1200/PO.22.00559 |
Ejemplares similares
-
Dynamic Changes in the Clonal Structure of MDS and AML in Response to Epigenetic Therapy
por: Uy, Geoffrey L., et al.
Publicado: (2016) -
A genomic analysis of Philadelphia chromosome-negative AML arising in patients with CML
por: Krysiak, K, et al.
Publicado: (2016) -
Targeted Sequencing Informs the Evaluation of Normal Karyotype Cytopenic Patients for Low-Grade Myelodysplastic Syndrome
por: Duncavage, Eric J., et al.
Publicado: (2016) -
Frequency of infusion-related reactions with CPX-351 treatment in an observational study in adults with newly diagnosed therapy-related AML or AML with myelodysplasia-related changes (AML-MRC)
por: Jacoby, Meagan A., et al.
Publicado: (2021) -
Reducing INDEL calling errors in whole genome and exome sequencing data
por: Fang, Han, et al.
Publicado: (2014)